Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
J&J's COVID-19 vaccine shows promise against Delta variant
J&J's COVID-19 vaccine shows promise against Delta variantJuly 2 (Reuters) - Johnson & Johnson (JNJ.
GSK, Alector to develop Parkinson's, Alzheimer's drugs in $2.2 bln deal
July 2 (Reuters) - GlaxoSmithKline Plc (GSK.
Philip Morris International Announces Agreement to Acquire Fertin Pharma
LAUSANNE, Switzerland--(BUSINESS WIRE)--Jul.
FDA Approves Rylaze for Subsets of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
The FDA has granted approval to Rylaze for use within a chemotherapy regimen to treat adult and pediatric patients with acute lymphoblastic leukemia and lymphoblastic lymphoma who are allergic to the ...
CureVac Final Data from Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection in Age Group of 18 to 60
TÜBINGEN, Germany / BOSTON, USA – June 30, 2021.
From 30 million cases to zero: China is certified malaria-free by WHO
Following a 70-year effort, China has been awarded a malaria-free certification from WHO – a notable feat for a country that reported 30 million cases of the disease annually in the 1940s.
Heart failure is associated with an increased risk of cancer
Sophia Antipolis – 28 June 2021.
Walmart Revolutionizes Insulin Access & Affordability for Patients With Diabetes With the Launch of the First and Only Private Brand Analog Insulin
BENTONVILLE, Ark.
MHRA approves Paion’s ‘ultra-short-acting’ anaesthetic Byfavo
Paion’s ‘ultra-short-acting’ anaesthetic Byfavo has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for use in procedural sedation.
Gilead seeks US approval for long-acting HIV drug lenacapavir
Gilead has filed its investigational long-acting HIV drug lenacapavir with the US Food and Drug Administration (FDA), seeking approval in patients with multi-drug resistant infection.
New clues point to the liver playing a causal role in type 2 diabetes
Researchers investigating new diabetes treatments believe they have found evidence indicating excess production of a key neurotransmitter in the liver could be a key causal factor in the onset of insu...
Sanofi offloads 16 consumer health brands to Stada amid CEO Hudson's refocusing effort
Amid a reorganization scheme aimed at slashing costs and prioritizing immunology blockbuster Dupixent, Sanofi is hiving off a clutch of consumer brands sold mainly in Europe.
239
240
241
242
243
244
245
246
247
